SURGALIGN HOLDINGS INC (SRGA) Stock Price, Forecast & Analysis

NASDAQ:SRGA • US86882C2044

0.1829 USD
-0.09 (-32.98%)
At close: Jun 30, 2023
0.1235 USD
-0.06 (-32.48%)
After Hours: 6/30/2023, 8:00:01 PM

SRGA Key Statistics, Chart & Performance

Key Statistics
Market Cap1.68M
Revenue(TTM)78.12M
Net Income(TTM)-50.49M
Shares9.18M
Float8.21M
52 Week High6.77
52 Week Low0.17
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-5.81
PEN/A
Fwd PEN/A
Earnings (Next)08-07
IPO2000-08-10
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
SRGA short term performance overview.The bars show the price performance of SRGA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

SRGA long term performance overview.The bars show the price performance of SRGA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SRGA is 0.1829 USD. In the past month the price decreased by -75.93%. In the past year, price decreased by -94.35%.

SURGALIGN HOLDINGS INC / SRGA Daily stock chart

SRGA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating
SRGA Full Technical Analysis Report

SRGA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to SRGA. SRGA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
SRGA Full Fundamental Analysis Report

SRGA Financial Highlights

Over the last trailing twelve months SRGA reported a non-GAAP Earnings per Share(EPS) of -5.81. The EPS increased by 50.34% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%57.14%
Sales Q2Q%-18.72%
EPS 1Y (TTM)50.34%
Revenue 1Y (TTM)-11.04%
SRGA financials

SRGA Forecast & Estimates

10 analysts have analysed SRGA and the average price target is 2.3 USD. This implies a price increase of 1154.78% is expected in the next year compared to the current price of 0.1829.

For the next year, analysts expect an EPS growth of -58.25% and a revenue growth -37.13% for SRGA


Analysts
Analysts82
Price Target2.3 (1157.52%)
EPS Next Y-58.25%
Revenue Next Year-37.13%
SRGA Analyst EstimatesSRGA Analyst Ratings

SRGA Ownership

Ownership
Inst Owners0%
Ins Owners110.88%
Short Float %N/A
Short RatioN/A
SRGA Ownership

SRGA Competitors/Peers

The largest stocks on the US markets in the "Health Care Supplies" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
MDLN MEDLINE INC-CL A30.4258.526B
COO COOPER COS INC/THE17.9516.264B
ALGN ALIGN TECHNOLOGY INC16.7113.401B
SOLV SOLVENTUM CORP11.4313.104B
MMSI MERIT MEDICAL SYSTEMS INC19.94.842B
LNTH LANTHEUS HOLDINGS INC12.484.601B
ICUI ICU MEDICAL INC18.133.578B
HAE HAEMONETICS CORP/MASS10.72.684B
XRAY DENTSPLY SIRONA INC8.022.584B
NEOG NEOGEN CORP32.32.38B

About SRGA

Company Profile

SRGA logo image Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 217 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology platform, is designed to automatically recognize, identify, and segment patient anatomy to autonomously assist the surgeon throughout the surgical procedure. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. Its market and sell products to hospitals, ambulatory surgery centers, and healthcare providers in the United States.

Company Info

SURGALIGN HOLDINGS INC

520 Lake Cook Rd Ste 315

Deerfield ILLINOIS 60015 US

CEO: Terry M. Rich

Employees: 217

SRGA Company Website

Phone: 18773436832.0

SURGALIGN HOLDINGS INC / SRGA FAQ

What does SURGALIGN HOLDINGS INC do?

Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 217 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing artificial intelligence (AI) and augmented reality (AR) technology platform called HOLO AI, which is an AI software technology, which connects the continuum of care from the pre-op and clinical-stage through post-op care. Its HOLO Portal surgical guidance system, a component of its HOLO AI technology platform, is designed to automatically recognize, identify, and segment patient anatomy to autonomously assist the surgeon throughout the surgical procedure. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. Its market and sell products to hospitals, ambulatory surgery centers, and healthcare providers in the United States.


What is the stock price of SURGALIGN HOLDINGS INC today?

The current stock price of SRGA is 0.1829 USD. The price decreased by -32.98% in the last trading session.


What is the dividend status of SURGALIGN HOLDINGS INC?

SRGA does not pay a dividend.


What is the ChartMill technical and fundamental rating of SRGA stock?

SRGA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What is the analyst forecast for SRGA stock?

10 analysts have analysed SRGA and the average price target is 2.3 USD. This implies a price increase of 1154.78% is expected in the next year compared to the current price of 0.1829.


Is SURGALIGN HOLDINGS INC (SRGA) expected to grow?

The Revenue of SURGALIGN HOLDINGS INC (SRGA) is expected to decline by -37.13% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the market cap for SURGALIGN HOLDINGS INC?

SURGALIGN HOLDINGS INC (SRGA) has a market capitalization of 1.68M USD. This makes SRGA a Nano Cap stock.